The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.

 
Web www.patentalert.com

< PRO1347 polypeptides

< PRO697 polypeptides

> Oral capsule formulation with increased physical stability

> Anti-PRO788 antibodies

~ 00245